“Assessment of AST ALT Ratio As a Significant Predictor of the Incidence Risk of Prostate Cancer”. Journal of Pharmaceutical Negative Results, Sept. 2022, pp. 1103-6, https://doi.org/10.47750/pnr.2022.13.S03.172.